BAJAJ BROKING

Notification close image
No new Notification messages
card image
NSDL IPO is Open!
Apply for the National Securities Depository Ltd (NSDL) IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

757885

544449

ANTHEM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Anthem Biosciences Ltd performance

Today’s low

Today’s high

₹ 747.05 ₹ 788.35
₹ 782.45

52 week low

52 week high

₹ 701.90 ₹ 788.35
₹ 782.45

Open Price

₹ 747.60

Prev. Close

₹ 755.90

Volume (Shares)

4307521.00

Total traded value

₹ 33704.19

Upper Circuit

₹ 907.05

Lower Circuit

₹ 604.75

info

Anthem Biosciences Ltd Share Price Update

As of the latest trading session, Anthem Biosciences Ltd share price is currently at ₹ 782.45, which is up by ₹ 26.54 from its previous closing. Today, the stock has fluctuated between ₹ 747.05 and ₹ 788.35. Over the past year, Anthem Biosciences Ltd has achieved a return of 0.00 %. In the last month alone, the return has been 0.00 %. Read More...

Investment Returns

Over 1 Month 0.00% Over 3 Months 0.00% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Anthem Biosciences Ltd fundamentals


  • Market cap (Cr)

    43,943.20

  • P/E Ratio (TTM)

    83.85

  • Beta

    0.86

  • Book Value / share

    44.04

  • Return on equity

    22.98%

  • EPS (TTM)

    9.02

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    43,988.10

  • P/E Ratio (TTM)

    83.85

  • Beta

    0.75

  • Book Value / share

    44.04

  • Return on equity

    22.98%

  • EPS (TTM)

    9.02

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Anthem Biosciences Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 1840.65
Operating Expense 1238.66
Net Profit 506.19
Net Profit Margin (%) 27.50
Earnings Per Share (EPS) 9.05
EBITDA 798.45
Effective Tax Rate (%) 28.84
Particulars MAR 2024 (Values in Cr)
Revenue 1417.54
Operating Expense 1003.28
Net Profit 374.78
Net Profit Margin (%) 26.43
Earnings Per Share (EPS) 6.61
EBITDA 575.40
Effective Tax Rate (%) 22.68
Particulars MAR 2025 (Values in Cr)
Book Value / Share 43.10
ROE % 20.82
ROCE % 28.24
Total Debt to Total Equity 0.08
EBITDA Margin 41.03
Particulars MAR 2024 (Values in Cr)
Book Value / Share 34.43
ROE % 20.04
ROCE % 23.98
Total Debt to Total Equity 0.10
EBITDA Margin 40.07
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.51
ROE % 22.25
ROCE % 27.36
Total Debt to Total Equity 0.05
EBITDA Margin 48.81
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1543.93
ROE % 39.44
ROCE % 49.35
Total Debt to Total Equity 0.07
EBITDA Margin 49.87
Particulars MAR 2021 (Values in Cr)
Book Value / Share 826.75
ROE % 38.68
ROCE % 46.14
Total Debt to Total Equity 0.14
EBITDA Margin 40.33
Particulars MAR 2025 (Values in Cr)
Book Value / Share 44.24
ROE % 22.98
ROCE % 30.46
Total Debt to Total Equity 0.06
EBITDA Margin 43.39
Particulars MAR 2024 (Values in Cr)
Book Value / Share 34.58
ROE % 20.40
ROCE % 24.74
Total Debt to Total Equity 0.08
EBITDA Margin 40.60
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.53
ROE % 22.27
ROCE % 27.47
Total Debt to Total Equity 0.05
EBITDA Margin 48.86
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1544.46
ROE % 39.48
ROCE % 49.38
Total Debt to Total Equity 0.07
EBITDA Margin 49.90
Particulars MAR 2021 (Values in Cr)
Book Value / Share 826.76
ROE % 48.30
ROCE % 53.40
Total Debt to Total Equity 0.23
EBITDA Margin 40.33
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 316.98
Total Assets 2807.58
Total Liabilities 2807.58
Total Equity 2409.86
Share Outstanding 559077100
Price to Book Ratio 0.00
Return on Assets (%) 16.07
Return on Capital (%) 17.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 184.35
Total Assets 2398.11
Total Liabilities 2398.11
Total Equity 1924.65
Share Outstanding 559077100
Price to Book Ratio 0.00
Return on Assets (%) 15.31
Return on Capital (%) 17.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 342.84
Total Assets 2014.45
Total Liabilities 2014.45
Total Equity 1740.66
Share Outstanding 570486800
Price to Book Ratio 0.00
Return on Assets (%) 19.12
Return on Capital (%) 20.65
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 310.95
Total Assets 2835.56
Total Liabilities 2835.56
Total Equity 2473.21
Share Outstanding 559077100
Price to Book Ratio 0.00
Return on Assets (%) 17.85
Return on Capital (%) 19.6
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 183.84
Total Assets 2324.22
Total Liabilities 2324.22
Total Equity 1933.07
Share Outstanding 559077100
Price to Book Ratio 0.00
Return on Assets (%) 16.12
Return on Capital (%) 17.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 342.79
Total Assets 1993.01
Total Liabilities 1993.01
Total Equity 1741.61
Share Outstanding 570486800
Price to Book Ratio 0.00
Return on Assets (%) 19.35
Return on Capital (%) 20.78
Particulars MAR 2025 (Values in Cr)
Net Income 656.86
Cash from Operations 577.33
Cash from Investing -152.11
Cash from Financing -133.60
Net change in Cash 132.62
Free Cash Flow 891.86
Particulars MAR 2024 (Values in Cr)
Net Income 477.31
Cash from Operations 260.15
Cash from Investing -221.45
Cash from Financing -77.18
Net change in Cash -158.48
Free Cash Flow 369.57
Particulars MAR 2023 (Values in Cr)
Net Income 497.29
Cash from Operations 420.98
Cash from Investing -376.01
Cash from Financing 63.97
Net change in Cash -6.05
Free Cash Flow 599.66
Particulars MAR 2022 (Values in Cr)
Net Income 546.14
Cash from Operations 455.91
Cash from Investing -205.45
Cash from Financing 180.67
Net change in Cash 308.13
Free Cash Flow 478.29
Particulars MAR 2021 (Values in Cr)
Net Income 365.56
Cash from Operations 348.28
Cash from Investing -196.03
Cash from Financing -63.26
Net change in Cash 18.33
Free Cash Flow 464.10
Particulars MAR 2025 (Values in Cr)
Net Income 711.42
Cash from Operations 598.83
Cash from Investing -246.31
Cash from Financing -66.42
Net change in Cash 127.10
Free Cash Flow 823.41
Particulars MAR 2024 (Values in Cr)
Net Income 484.77
Cash from Operations 284.40
Cash from Investing -191.75
Cash from Financing -131.59
Net change in Cash -158.94
Free Cash Flow 388.25
Particulars MAR 2023 (Values in Cr)
Net Income 497.78
Cash from Operations 433.98
Cash from Investing -377.90
Cash from Financing 52.85
Net change in Cash -6.07
Free Cash Flow 612.66
Particulars MAR 2022 (Values in Cr)
Net Income 546.59
Cash from Operations 456.34
Cash from Investing -205.77
Cash from Financing 180.67
Net change in Cash 308.24
Free Cash Flow 478.73
Particulars MAR 2021 (Values in Cr)
Net Income 365.57
Cash from Operations 348.19
Cash from Investing -196.08
Cash from Financing -63.26
Net change in Cash 18.19
Free Cash Flow 464.01
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.27 28.56 1.76 247.30 32.00 / 73.95
BLISS GVS PHARMA LTD 155.10 19.41 1.55 1636.27 105.05 / 184.95
CIPLA LTD 1570.95 23.53 4.06 126893.68 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 377.00 13.69 3.05 1109.55 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 32.27 82.74 5.09 247.30 32.00 / 73.95
AMRUTAJAN HEALTH LTD 661.15 37.61 5.85 1911.43 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8945.00 127.69 29.02 22362.50 6222.35 / 10653.05
BLISS GVS PHARMA LTD 155.10 23.68 1.54 1636.27 105.05 / 184.95

Anthem Biosciences Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
782.45 3.51 redarrow
red-green-graph indicator
7 Bearish
9 Bullish
  • 5 Days 749.90
  • 26 Days 748.40
  • 10 Days 748.40
  • 50 Days 748.40
  • 12 Days 748.40
  • 100 Days 748.40
  • 20 Days 748.40
  • 200 Days 748.40
752.70 PIVOT

First Support

745.45

First Resistance

763.15

Second Support

735.00

Second Resistance

770.40

Third Support

727.75

Third Resistance

780.85

RSI

92.09

ADX

26.62

MACD

0.00

Williams % R

-20.70

Commodity Channel Index (CCI)

165.79

Date

2025-07-28

Week

6522678.00

Same Day

1173786.00

Month

6522678.00

1 Year

0.86

3 Year

0.78

Over 1 Month

0.00%

down

Over 1 Year

0.00%

down

Over 3 Months

0.00%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Anthem Biosciences Ltd shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
20.46%
Promoter Holdings
74.68%
FII
1.49%
DII
3.34%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Ajay Bhardwaj 2.38869615E8 (42.53%) Shareholding of Promoter and Promoter Group
Ishaan Bhardwaj 5.704868E7 (10.16%) Shareholding of Promoter and Promoter Group
Ganesh Sambasivam 4.5670027E7 (8.13%) Shareholding of Promoter and Promoter Group
K C Ravindra 4.3646849E7 (7.77%) Shareholding of Promoter and Promoter Group
Vridity Tone LLP 2.1313795E7 (3.8%) Public Shareholding
Portsmouth Technologies LLC 1.5369327E7 (2.74%) Public Shareholding
Satish S Sharma 1.2748838E7 (2.27%) Public Shareholding
Rupesh Narharrao Kinekar 1.2748838E7 (2.27%) Public Shareholding
Malay Jiban Barua 1.2748838E7 (2.27%) Public Shareholding
Aruna Ganesh 8557302.0 (1.52%) Shareholding of Promoter and Promoter Group
Krithika Ganesh 8557302.0 (1.52%) Shareholding of Promoter and Promoter Group
S Vijayalakshmi 5704868.0 (1.02%) Shareholding of Promoter and Promoter Group
Swara Trust (Trustee K C Ravindra) 5704868.0 (1.02%) Shareholding of Promoter and Promoter Group
Vira Trust (Truetee K C Ravindra) 5704868.0 (1.02%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Anthem Biosciences Ltd corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Anthem Biosciences Ltd Share Price

Anthem Biosciences Limited was originally incorporated as 'Anthem Biosciences Private Limited', dated June 13, 2006, issued by RoC. Subsequently, Company was converted from a Private Company to a Public Company , followed by the change in name of the Company to 'Anthem Biosciences Limited' and a Certificate of Incorporation was issued by RoC on December 10, 2024.

The Company has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries.

The Company started operations at Unit I and set up a Custom Synthesis Plant with a capacity of 6 KL in year 2007. It commenced discovery biology services with a fermentation capacity of 2 KL in 2008. It expanded the Custom Synthesis Plant at Unit I increasing its capacity from 6 KL to 24 KL in 2010. It set up a high potent lab at Unit I - Bommasandra Facility in 2016. The Company was merged with Anthem Cellutions (India) Private Limited by acquiring 100% of its share capital in November, 2017. It set up a flow chemistry lab scale and solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1. It commenced operations of the Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL in 2018-19. In year 2020, Company started operations to biological unit 2 earmarked for a specific client. It expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL. In FY 2024, Company set up a wholly owned subsidiary Neoanthem Lifesciences Private Limited and commenced operations at Unit III for development in projects.

Company launched the initial public offering of 59,575,319 equity shares of face value of Rs 2 each by raising funds through offer for sale aggregating to Rs 3395 Crore in July, 2025.

The Company expanded the fermentation capacity to 140 KL at the Unit II in 2025.

Parent organization Indian Private
NSE symbol ANTHEM
Founded 2006
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Anthem Biosciences Ltd?

Answer Field

Anthem Biosciences Ltd share price is for NSE ₹ 782.45 & for BSE ₹ 783.25 as on Jul 29 2025 03:30 PM.

What is the Market Cap of Anthem Biosciences Ltd Share?

Answer Field

The market cap of Anthem Biosciences Ltd for NSE ₹ 43,744.99 & for BSE ₹ 43,789.71 as on Jul 29 2025 03:30 PM.

What is the 52 Week High and Low of Anthem Biosciences Ltd?

Answer Field

The 52 Week High and Low of Anthem Biosciences Ltd for NSE is ₹ 788.35 and ₹ 701.90 and for BSE is ₹ 789.00 and ₹ 701.75.

What is 1 year return for Anthem Biosciences Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Anthem Biosciences Ltd Share?

Answer Field

As on Jul 29 2025 03:30 PM the price-to-earnings (PE) ratio for Anthem Biosciences Ltd share is 83.85.

What is the PB ratio of Anthem Biosciences Ltd Share?

Answer Field

As on Jul 29 2025 03:30 PM, the price-to-book (PB) ratio for Anthem Biosciences Ltd share is 44.04.

How to Buy Anthem Biosciences Ltd Share?

Answer Field

You can trade in Anthem Biosciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Anthem Biosciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Anthem Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Anthem Biosciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|